Didrogyl oral drops

Didrogyl is a specialized pharmaceutical product used primarily for the treatment of vitamin D deficiency and related bone disorders. The active ingredient is calcifediol, which is a metabolite of vitamin D3 that allows for faster absorption in the body. The product is frequently distributed within the Italian market, as indicated by the 'Confezione Dispensata SSN' label, which refers to the Italian National Health Service.

The brand has long been associated with the French pharmaceutical giant Roussel Uclaf, which was later integrated into what became Sanofi. Today, the product remains a key part of the pharmacological portfolio for metabolic bone diseases. While the brand has historical roots in France and international development, this specific packaging is manufactured and regulated for the Italian pharmaceutical sector, often produced at specialized facilities within Italy or the European Union belonging to the Sanofi Group.